Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7501 p567
10 May 2008

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• New professional body (2)
• Council election (2)
• Trimethoprim
• Restricted title
• Addiction
• Medicines use reviews
• English Pharmacy Board
• Epilepsy
• Euthanasia
• Public relations
• The Society


Letters to the Editor

English Pharmacy Board

Engagement with branches and regions

From Mr R.J. Daniszewski, MRPharmS

I want to bring PJ readers up to date with work that the English Pharmacy Board is doing to scope the future of the Royal Pharmaceutical Society regions. I, along with fellow board members Paul Bennett and Seema Agha, recently hosted an informal dinner for regional secretaries, which provided the opportunity to discuss possible new ways of working and to hear views about what resources should be provided to support practising and non-practising members at the local level in the future. The dinner also provided a forum for discussion on the structure of the new professional body.

I was impressed by the passion and genuine enthusiasm from those at the evening to work to achieve positive change. The Society’s local network provides an important platform for dialogue, networking and social interaction for members.

The new professional body will need to consider very carefully how it will support members through local structures and facilitate working relationships across all levels. Members will be given an opportunity to explore the opportunities for new support structures at the branch representatives’ meeting to be held in London on 22 May 2008.

I urge branch members to make their views known to their branch representatives to ensure that the session explores the needs of members in various settings and especially those members who are not currently actively engaged in the branch and regional network.

Richard Daniszewski
Lead for Branches and Regions
English Pharmacy Board

Send your letter to The Editor

Previous Topic (Medicines use reviews)
Next Topic (Epilepsy)

Back to Top


©The Pharmaceutical Journal